FDA Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft
标准简介
Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接]是于不久之前发布的FDA标准,适用于美国。标准截图
![Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接]](/img/20210914103712vg8n1.jpg)
标准文档说明
标准文档类型为Denture Base Resins – Performance Criteria for Safety and Performance Based Pathway Draft[附网盘链接]高清PDF版本(文字版),标准文档内可进行搜索,可以复制原文,可粘贴。标准部分原文
Draft – Not for Implementation
47 Denture Base Resins – Performance 48 Criteria for Safety and Performance 49 Based Pathway
50 ______________________________________________________________________________
51 Draft Guidance for Industry and
52 Food and Drug Administration Staff
53
54 This draft guidance, when finalized, will represent the current thinking of the Food and Drug 55 Administration (FDA or we) on this topic. It does not establish any rights for any person and 56 is not binding on FDA or the public. You can use an alternative approach if it satisfies the 57 requirements of the applicable statutes and regulations. To discuss an alternative approach, 58 contact the FDA staff or Office responsible for this guidance as listed on the title page.
59 I. Introduction
60 This draft guidance provides performance criteria for denture base resins in support of the Safety 1
61 and Performance Based Pathway. Under this framework, submitters (you) planning to submit a 62 510(k) using the Safety and Performance Based Pathway for denture base resins will have the 63 option to use the performance criteria proposed in this draft guidance to support substantial 64 equivalence, rather than a direct comparison of the performance of the subject device to that of a 65 predicate device.
66
67 For the current edition of the FDA-recognized consensus standard(s) referenced in this 2
68 document, see the FDA Recognized Consensus Standards Database. For more information 69 regarding use of consensus standards in regulatory submissions, please refer to the FDA 70 guidance titled Appropriate Use of Voluntary Consensus Standards in Premarket Submissions 3
71 for Medical Devices. 72
73 The contents of this document do not have the force and effect of law and are not meant to bind 74 the public in any way, unless specifically incorporated into a contract. This document is intended 75 only to provide clarity to the public regarding existing requirements under the law. FDA 76 guidance documents, including this guidance, should be viewed only as recommendations, unless 1
Available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/safety-and-performance-
based-pathway 2
Available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm 3
Available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/appropriate-use-
voluntary-consensus-standards-premarket-submissions-medical-devices
网盘链接
百度网盘:https://pan.baidu.com/s/1abs6fjqidNYB8jamwZ31cw
提取码:2a1q
【温馨提示】大资料ISO是提供信息发布的专业信息类网站,所有内容均由用户发布,不代表本站观点,本站亦不存储所涉及的文件及资料。如有【免费资料】以及【付费资料】,请用户根据自己的需求,自行判断是否需要获取。如有交易诈骗、内容侵权可发送邮件至kf@dzl100.com,我们审查后若发现情况属实,会立即对相关内容进行删除处理。
加载用时:41.2152 毫秒
相关评论
相关文章
-
ISO 19206-3:2021 Road vehicles — Test devices for target vehicles, vulnerable road users and other objects, for assessment of active safety functions —Part 3: Requirements for passenger vehicle 3D targets
Road vehicles — Test devices for target vehicles, vulnerable road users and other objects, for assessment of active safety functions —Part 3: Requirements for passenger vehicle 3D targets是ISO于2021‑05‑21发布的ISO标准,适用于全球范围。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
IMDRF/GRRP WG/N47 FINAL:2018 Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices - PDF (260kb)
Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices - PDF (260kb)[附网盘链接]是IMDRF Good Regulatory Review Practices Group于31 October 2018发布的GHTF标准,适用于世界。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
GHTF/SG2/N57R8:2006 GHTF SG2 - Guidance - Content of Field Safety Notices - PDF (58kb)
GHTF SG2 - Guidance - Content of Field Safety Notices - PDF (58kb)[附网盘链接]是Study Group 2于27 June 2006发布的GHTF标准,适用于全球。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
CVM GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products.pdf[网盘链接]
GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products.pdf是于发布的标准,适用于。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
ISO 15638-24:2021 Intelligent transport systems — Framework for collaborative telematics applications for regulated commercial freight vehicles (TARV) —Part 24: Safety information provisioning
Intelligent transport systems — Framework for collaborative telematics applications for regulated commercial freight vehicles (TARV) —Part 24: Safety information provisioning是ISO于2021‑06‑21发布的ISO标准,适用于全球。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers[附网盘链接]是Food&Drug Administration于不久前发布的FDA标准,适用于U.S。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Exculpatory Language in Informed Consent
Exculpatory Language in Informed Consent[附网盘链接]是FDA于不久前发布的FDA标准,适用于美国。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products
Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products[附网盘链接]是Food And Drug Administration于不久之前发布的FDA标准,适用于US。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Adverse Accreditation Decisions, SuspensionRevocation of Certificates, or Patient and Physician Notification Orders Draft
Adverse Accreditation Decisions, SuspensionRevocation of Certificates, or Patient and Physician Notification Orders Draft[附网盘链接]是Food And Drug Administration于不久之前发布的FDA标准,适用于United States。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
CVM GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products.pdf[网盘链接]
GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products.pdf是于发布的标准,适用于。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances
Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances[附网盘链接]是FDA于过去发布的FDA标准,适用于美国。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry
Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry[附网盘链接]是FDA于过去发布的FDA标准,适用于美国。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Assay Migration Studies for In Vitro Diagnostic Devices Guidance for Industry and FDA Staff
Assay Migration Studies for In Vitro Diagnostic Devices Guidance for Industry and FDA Staff[附网盘链接]是FDA于过去发布的FDA标准,适用于United States。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Clinical Pharmacology Labeling for Human Prescription Drug and Biological Products — Content and Format
Clinical Pharmacology Labeling for Human Prescription Drug and Biological Products — Content and Format[附网盘链接]是Food And Drug Administration于当前发布的FDA标准,适用于United States。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。
-
FDA Chronic Hepatitis D Virus Infection Developing Drugs for Treatment Guidance for Industry
Chronic Hepatitis D Virus Infection Developing Drugs for Treatment Guidance for Industry[附网盘链接]是Food&Drug Administration于当前发布的FDA标准,适用于United States。本次分享的标准文档为高清PDF(文字版),标准文档内可搜索,可复制,可粘贴。本文结尾附网盘链接。